Aneustat (OMN54) has aerobic glycolysis-inhibitory activity...

  • Main
  • 2018 / 02
  • Aneustat (OMN54) has aerobic glycolysis-inhibitory activity...

Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model

Qu, Sifeng, Xue, Hui, Dong, Xin, Lin, Dong, Wu, Rebecca, Nabavi, Noushin, Collins, Colin C., Gleave, Martin E., Gout, Peter W., Wang, Yuzhuo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.31310
Date:
February, 2018
File:
PDF, 1.38 MB
english, 2018
Conversion to is in progress
Conversion to is failed